Gastroesophageal Reflux Disease (GERD)/Nighttime Heartburn and Driving Performance
NCT01079884
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class
Conditions
GERD
Interventions
DRUG:
esomeprazole 40 mg
Sponsor
David A. Johnson, MD
Collaborators
[object Object]